Report on a cluster of 2019 novel coronavirus cases in Wuhan, China

February 13, 2020

Share article

The authors report on the epidemiological, clinical, laboratory and radiological characteristics, treatment and clinical outcomes of a cluster of patients with pneumonia in Wuhan, China, caused by the 2019 novel coronavirus (2019-nCoV). By start of January 2020, 41 admitted hospital patients had been diagnosed with laboratory-confirmed 2019-nCoV infection. 73% of the infected patients were men and 32% had underlying diseases, including diabetes (20%), hypertension (15%) and cardiovascular disease (15%). Median age was 49·0 years. 66% of the patients had been exposed to Huanan seafood market. One family cluster was identified. Common symptoms at the onset of illness were fever (98%), cough (76%), and myalgia or fatigue (44%). Less common symptoms were: sputum production (28%), headache (8%), haemoptysis (5%) and diarrhoea (3%). Dyspnoea developed in 55% of patients (median time from illness onset to dyspnoea 8·0 days). 63% of the patients had lymphopenia. All 41 patients had pneumonia with abnormal findings on chest CT. Complications included: acute respiratory distress syndrome (29%), RNAaemia (15%), acute cardiac injury (12%) and secondary infection (10%). 32% of patients were admitted to an intensive care unit (ICU) and 15% of patients died. Compared with the non-ICU patients, ICU patients had higher plasma levels of IL2, IL7, IL10, GCSF, IP10, MCP1, MIP1A and TNFα. Therefore the 2019-nCoV infection can cause clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and is associated with ICU admission and high mortality.

Read more here

Huang C, Wang Y, Li X, Ren L, Zhao J, et al. ISSN: Lancet; pii: S0140-6736(20)30183-5


Added: February 13, 2020